Table 4.
Relationship between FAR and first-ever CVE.
| FAR ≥ 0.107 (vs. FAR < 0.107) |
Age (per 1 year increase) |
|||
|---|---|---|---|---|
| HR (95%CI) | p Value | HR (95%CI) | p Value | |
| Unadjusted | 1.867 (1.253–2.782) | .002 | 1.035 (1.019–1.051) | <.001 |
| Model 1 | 1.611 (1.073–2.419) | .022 | 1.031 (1.016–1.047) | <.001 |
| Model 2 | 1.549 (1.028–2.333) | .036 | 1.028 (1.013–1.044) | <.001 |
| Model 3 | 1.676 (1.041–2.698) | .034 | 1.023 (1.004–1.042) | .016 |
FAR: fibrinogen/albumin ratio; CVE: cardiovascular event; HR: hazard ratio; 95%CI: 95% confidence interval.
Model 1: age, sex, body mass index; model 2: model 1 plus history of diabetes, and history of cardiovascular disease; model 3: model 2 plus haemoglobin, serum creatinine, corrected serum calcium, serum phosphorus, total Kt/V and residual renal function.